REG - Indivior PLC - Indivior to Participate in Upcoming Events

IndiviorAnnouncement

Today 15:00

For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20250513:nRSM5042Ia&default-theme=true

RNS Number : 5042I  Indivior PLC  13 May 2025

 

 

Indivior to Participate in Upcoming Investor Events

Richmond, VA,  May 13, 2025 - Indivior PLC (NASDAQ/LSE: INDV) today announced
that it will participate in the following investor events:

 

·    Jefferies Global Healthcare Conference - New York City, NY

Joe Ciaffoni, Chief Executive Officer, and Ryan Preblick, Chief Financial
Officer, will host 1x1 / group meetings on Wednesday, June 4(th).  Joe
Ciaffoni will also participate in a fireside discussion on Wednesday, June
4(th) at 9:55 a.m. U.S. ET.  Interested investors should contact their
Jefferies representative to schedule a meeting.  The fireside discussion will
be publicly available and can be viewed using the following weblink:

Webcast Link (https://wsw.com/webcast/jeff319/indv.l/2077832)

 

·    Goldman Sachs 46(th) Annual Global Healthcare Conference - Miami, FL

Joe Ciaffoni, Chief Executive Officer, and Ryan Preblick, Chief Financial
Officer, will host 1x1 / group meetings on Wednesday, June 11(th).
Interested investors should contact their Goldman Sachs representative to
schedule a meeting.

 

·    Northland Growth Conference 2025 - Virtual

Joe Ciaffoni, Chief Executive Officer, and Ryan Preblick, Chief Financial
Officer, will host 1x1 / group meetings virtually on Wednesday, June 25(th).
Interested investors should contact their Northland representative to schedule
a meeting.

 

 

About Indivior

Indivior is a global pharmaceutical company working to help change patients'
lives by developing medicines to treat substance use disorders (SUD). Our
vision is that all patients around the world will have access to
evidence-based treatment for the chronic conditions and co-occurring disorders
of SUD. Indivior is dedicated to transforming SUD from a global human crisis
to a recognized and treated chronic disease. Building on its global portfolio
of OUD treatments, Indivior has a pipeline of product candidates designed to
expand on its heritage in this category. Headquartered in the
United States in Richmond, VA, Indivior employs over 1,000 individuals
globally and its portfolio of products is available in over 30 countries
worldwide. Visit www.indivior.com
(https://nam12.safelinks.protection.outlook.com/?url=https%3A%2F%2Fc212.net%2Fc%2Flink%2F%3Ft%3D0%26l%3Den%26o%3D4271839-1%26h%3D3117038971%26u%3Dhttps%253A%252F%252Fc212.net%252Fc%252Flink%252F%253Ft%253D0%2526l%253Den%2526o%253D4245151-1%2526h%253D1246464342%2526u%253Dhttps%25253A%25252F%25252Fwww.indivior.com%25252Fen%2526a%253Dwww.indivior.com%26a%3Dwww.indivior.com&data=05%7C02%7Ctimothy.owens%40Indivior.com%7C31ce26374edf4dfbc1d408dd1edcf9af%7Cbed52191489442999db948e4fb29646e%7C1%7C0%7C638700656623483369%7CUnknown%7CTWFpbGZsb3d8eyJFbXB0eU1hcGkiOnRydWUsIlYiOiIwLjAuMDAwMCIsIlAiOiJXaW4zMiIsIkFOIjoiTWFpbCIsIldUIjoyfQ%3D%3D%7C0%7C%7C%7C&sdata=qBtFBN3PgUJr4tF%2FxBzFOXY0sja6ffl3Qq6Dmaam3hQ%3D&reserved=0)
 to learn more. Connect with Indivior on LinkedIn by
visiting www.linkedin.com/company/indivior
(https://nam12.safelinks.protection.outlook.com/?url=https%3A%2F%2Fc212.net%2Fc%2Flink%2F%3Ft%3D0%26l%3Den%26o%3D4271839-1%26h%3D2950697406%26u%3Dhttps%253A%252F%252Fc212.net%252Fc%252Flink%252F%253Ft%253D0%2526l%253Den%2526o%253D4245151-1%2526h%253D27799095%2526u%253Dhttp%25253A%25252F%25252Fwww.linkedin.com%25252Fcompany%25252Findivior%2526a%253Dwww.linkedin.com%25252Fcompany%25252Findivior.%26a%3Dwww.linkedin.com%252Fcompany%252Findivior&data=05%7C02%7Ctimothy.owens%40Indivior.com%7C31ce26374edf4dfbc1d408dd1edcf9af%7Cbed52191489442999db948e4fb29646e%7C1%7C0%7C638700656623515198%7CUnknown%7CTWFpbGZsb3d8eyJFbXB0eU1hcGkiOnRydWUsIlYiOiIwLjAuMDAwMCIsIlAiOiJXaW4zMiIsIkFOIjoiTWFpbCIsIldUIjoyfQ%3D%3D%7C0%7C%7C%7C&sdata=5%2B9q%2FWDjPihKkjrPzBYLC8dCtGvdAARoDOW3y6ABGvE%3D&reserved=0)
.

 

 

Contact:

Jason Thompson

Vice President, Investor Relations

Tel: 804-402-7123 or jason.thompson@indivior.com
(mailto:jason.thompson@indivior.com)

 

Tim Owens

Director, Investor Relations

Tel: 804-263-3978 or timothy.owens@indivior.com
(mailto:timothy.owens@indivior.com)

 

###

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  MSCFLFSVEVIVLIE